Lonza Group AG/Fr. LONN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Lonza Group AG
Lonza Group AG is a Swiss multinational chemicals and biotechnology company headquartered in Basel, Switzerland. The company operates primarily in the life sciences sector, offering products and services for pharmaceutical and biotechnology companies, including custom development and manufacturing of active pharmaceutical ingredients, cell and gene therapies, and bioscience solutions. Founded in 1897, Lonza has a significant global presence with numerous production and research facilities worldwide. The company's strategic positioning lies in its comprehensive offering that supports pharmaceutical companies from early-stage development through commercialization, leveraging advanced technologies and extensive expertise in biologics.
Ticker
Fr. LONN
Sector
Primary listing
XSWX
Employees
20,000
Headquarters
Basel, Switzerland
Website
Lonza Group AG Metrics
BasicAdvanced
CHF 34bn
35.95
CHF 13.51
0.82
CHF 5.00
0.51%
Price and volume
Market cap
CHF 34bn
Beta
0.82
52-week high
CHF 594.80
52-week low
CHF 454.60
Average daily volume
169k
Dividend rate
CHF 5.00
Financial strength
Current ratio
2.24
Quick ratio
0.624
Long term debt to equity
42.19
Total debt to equity
58.737
Interest coverage (TTM)
8.28%
Profitability
EBITDA (TTM)
2,137
Gross margin (TTM)
35.97%
Net profit margin (TTM)
-4.21%
Operating margin (TTM)
21.16%
Effective tax rate (TTM)
17.44%
Revenue per employee (TTM)
CHF 330,000
Management effectiveness
Return on assets (TTM)
4.46%
Return on equity (TTM)
10.48%
Valuation
Price to earnings (TTM)
35.951
Price to revenue (TTM)
5.209
Price to book
3.72
Price to tangible book (TTM)
4.97
Price to free cash flow (TTM)
-306.459
Free cash flow yield (TTM)
-0.33%
Free cash flow per share (TTM)
-1.585
Dividend yield (TTM)
1.03%
Forward dividend yield
0.51%
Growth
Revenue change (TTM)
19.18%
Earnings per share change (TTM)
51.46%
3-year revenue growth (CAGR)
1.62%
10-year revenue growth (CAGR)
5.56%
3-year earnings per share growth (CAGR)
-37.83%
10-year earnings per share growth (CAGR)
-2.88%
3-year dividend per share growth (CAGR)
12.62%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs